Skip to content

Probiotic trial found no clear bone-health advantage after menopause

In postmenopausal women, a probiotic supplement did not clearly improve hip-area bone density or estimated fracture risk compared with placebo over 48 weeks. This does not establish equivalence.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The tested probiotic did not show a statistically clear advantage over placebo for bone density near the hip or estimated fracture risk. Blood markers of bone activity also showed no mean difference between groups from the start to the end of the study. These results concern this supplement and population; they do not establish that every probiotic has the same effects.

Keep in mind

The abstract reports significance tests but not the size or uncertainty range of treatment differences. Fracture risk was estimated with a prediction tool, rather than established through a reported comparison of actual fractures.

THE RESULT, WITH CONTEXT

What researchers found

No clear difference in bone-density change

Bone mineral density at the femoral neck, near the hip

Probiotic versus placebo over 48 weeks; the test comparing changes over time was not statistically significant (p > 0.05).

Arch Osteoporos, 2025 · Original source ↓

What was measured

Researchers measured bone density at the femoral neck, near the hip, and calculated fracture risk using the FRAX assessment tool. They also measured blood markers of bone-cell activity at several points during the study.

Change over time differed from treatment benefit

Across treatment assignments, bone density declined and estimated fracture risks increased over time. Those overall changes do not show that the probiotic caused them; the comparison of changes between probiotic and placebo did not find a clear difference.

CHECK THE ORIGINAL

The original publication

Using probiotic supplementation to support bone health in postmenopausal women: a randomized, double-blind, parallel, placebo-controlled, multi-center study.

Yumol JL, Binda S, Nagulesapillai V et al.
Arch Osteoporos · 2025

PubMed ID
40715573
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.